Literature DB >> 1628160

The role of nitric oxide in the regional vasodilator effects of endothelin-1 in the rat.

J R Fozard1, M L Part.   

Abstract

1. The role of nitic oxide (NO) derived from L-arginine in the regional vasodilator effects of endothelin-1 has been investigated in anaesthetized, spontaneously hypertensive (SH) rats in which autonomic reflexes were abolished by ganglion blockade. The experimental design incorporated animals infused with phenylephrine to mimic the peripheral vasconstrictor effects of the NO biosynthesis inhibitors and a single dose per animal paradigm to obviate problems of tachyphylaxis to the vasodilator effects of endothelin-1. 2. Infusion of the inhibitor of NO synthase, N-monomethyl-L-arginine (L-NMMA) at a dose (5 mg kg-1 min-1) which maximally raised blood pressure did not influence either the fall in blood pressure or the vasodilator responses induced in the hindquarters and carotid vascular beds by endothelin-1 (1 nmol kg-1, i.v.) The duration (but not the initial magnitude) of the vasodepressor response to endothelin-1 was however significantly attenuated (by 49%) during infusion of the more potent inhibitor of NO synthase, NG-nitro-L-arginine methyl ester (L-NAME), 2 mg kg-1 min-1. 3. Increasing the dose of L-NAME to 10 and 25 mg kg-1min-1 significantly attenuated, but did not abolish, the falls in blood pressure and hindquarters vasodilator responses to acetylcholine, 1 microgram kg-1, and endothelin-1, 1 nmol kg-1 min-1. The effects were selective in that vasodepressor responses to the endothelium-independent vasodilator, sodium nitroprusside, 1-10 micrograms kg-1 min-1, were unaltered. The effects were selective in that vasodepressor responses to the endothelium-independent vasodilator, sodium nitroprusside, 1-l0mg kg min , were unaltered.4. The data indicate that NO generated de novo from L-arginine mediates a significant component of the vasodilator effect of endothelin-1 in the anaesthetized, ganglion-blocked SH rat. However, a major component of the vasodepressor effects of both endothelin-1 and acetylcholine may occur independently of this mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628160      PMCID: PMC1908454          DOI: 10.1111/j.1476-5381.1992.tb09049.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation.

Authors:  H L Lippton; G A Cohen; I F McMurtry; A L Hyman
Journal:  J Appl Physiol (1985)       Date:  1991-02

2.  Effects of endothelin in the systemic and renal vascular beds in vivo.

Authors:  H Lippton; J Goff; A Hyman
Journal:  Eur J Pharmacol       Date:  1988-10-11       Impact factor: 4.432

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Molecular mechanism of action of the vasoconstrictor peptide endothelin.

Authors:  C Van Renterghem; P Vigne; J Barhanin; A Schmid-Alliana; C Frelin; M Lazdunski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

5.  Massive regional differences in the vascular effects of endothelin.

Authors:  R P Hof; A Hof; Y Takiguchi
Journal:  J Hypertens Suppl       Date:  1989-12

6.  Endothelin-1 has a dilator effect on neonatal pig pulmonary vasculature.

Authors:  T Perreault; J De Marte
Journal:  J Cardiovasc Pharmacol       Date:  1991-07       Impact factor: 3.105

7.  Haemodynamic changes and acetylcholine-induced hypotensive responses after NG-nitro-L-arginine methyl ester in rats and cats.

Authors:  E Marcel van Gelderen; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

8.  Endothelin is a potent long-lasting vasoconstrictor in men.

Authors:  J G Clarke; N Benjamin; S W Larkin; D J Webb; G J Davies; A Maseri
Journal:  Am J Physiol       Date:  1989-12

9.  Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats.

Authors:  P Madeddu; C Troffa; N Glorioso; A Pazzola; A Soro; P Manunta; G Tonolo; M P Demontis; M V Varoni; V Anania
Journal:  J Cardiovasc Pharmacol       Date:  1989-12       Impact factor: 3.105

10.  Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

Authors:  J R Haywood; R A Shaffer; C Fastenow; G D Fink; M J Brody
Journal:  Am J Physiol       Date:  1981-08
View more
  8 in total

1.  Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.

Authors:  J G Filep; E Földes-Filep; A Rousseau; P Sirois; A Fournier
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.

Authors:  L McMurdo; P S Lidbury; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

Authors:  H Moritoki; H Miyano; S Takeuchi; M Yamaguchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

5.  Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.

Authors:  M Bigaud; J T Pelton
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

6.  Endothelins induce prostacyclin release in both vascular and non-vascular tissue.

Authors:  G G Mattera; R M Catalioto; M Criscuoli; A Subissi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

7.  Endothelin receptors mediating functional responses in human small arteries and veins.

Authors:  J Riezebos; I S Watts; P J Vallance
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

8.  Evidence for ETA and ETB receptors in rat skin and an investigation of their function in the cutaneous microvasculature.

Authors:  E Lawrence; L Siney; P Wilsoncroft; G A Knock; G Terenghi; J M Polak; S D Brain
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.